HEALTH Cosmo Pharmaceuticals N.V.: Cosmo Announces Completion of Phase II Enrolment in Distal Ulcerative Colitis Program Monday, May 18, 2026 Advertisement Read Original Article → Related Dispatches [EU] · May 21 Emerging Sub-Segments Transforming the Clinical Trials Market Landscape [US] · May 21 Dear Doctor: Neurosurgeon botched back surgery, pain is worse by the day; is there any hope? [EU] · May 21 KKR Invests in Fresha, the Leading AI-Powered Platform for Beauty and Wellness, at $1bn Valuation
